Rare diseases
Investigational molecules
Locations
Back to the Netherlands10 clinical trials in Zwijndrecht, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Efficacy and safety of oral semaglutide for weight loss in adults with overweight or obesity
The NetherlandsA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
The NetherlandsStudy of ISIS 678354 for Patients with Severe High Triglycerides
The NetherlandsStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
The NetherlandsStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
The NetherlandsStudy of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides
The NetherlandsA study to evaluate the effects of obicetrapib and ezetimibe on cholesterol levels in adults with type 2 diabetes or metabolic syndrome
The NetherlandsStudy on How Cagrilintide and Semaglutide Help People with Overweight or Obesity Reduce Weight
The NetherlandsStudy on the Safety and Effectiveness of Diamyd and Colecalciferol for Adolescents and Adults with Recently Diagnosed Type 1 Diabetes
The NetherlandsStudy on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on weight management and obesity treatment, evaluating new therapeutic approaches for individuals struggling with excess body weight. These trials aim to assess the effectiveness of novel medications combined with lifestyle modifications.
Current studies examine the impact of medication-assisted weight loss programs alongside dietary and physical activity modifications.
Critical research into atherosclerotic cardiovascular disease and hypertriglyceridemia, investigating new treatments for improving cardiovascular outcomes and managing blood lipid levels.
These trials focus on preventing major adverse cardiovascular events and improving treatment options for patients with established heart disease.
Groundbreaking research in Type 1 diabetes management, exploring innovative treatments to preserve insulin production in newly diagnosed patients. Studies focus on genetic factors and immune responses.
Current trials evaluate targeted treatments for specific genetic profiles in diabetes patients.
Essential research on COVID-19 treatment options, investigating new therapeutic approaches for high-risk outpatients. Studies aim to reduce hospitalization rates and improve patient outcomes.
Ongoing trials focus on developing effective treatments for managing COVID-19 in outpatient settings.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
